1. Home
  2. NCRA vs BMRA Comparison

NCRA vs BMRA Comparison

Compare NCRA & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nocera Inc.

NCRA

Nocera Inc.

HOLD

Current Price

$0.21

Market Cap

5.6M

ML Signal

HOLD

Logo Biomerica Inc.

BMRA

Biomerica Inc.

N/A

Current Price

$2.21

Market Cap

6.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NCRA
BMRA
Founded
2002
1971
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
6.6M
IPO Year
2022
1995

Fundamental Metrics

Financial Performance
Metric
NCRA
BMRA
Price
$0.21
$2.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
644.0K
23.3K
Earning Date
04-15-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,627,944.00
$5,311,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$1.87
52 Week High
$2.40
$4.60

Technical Indicators

Market Signals
Indicator
NCRA
BMRA
Relative Strength Index (RSI) 35.23 49.45
Support Level $0.18 $2.11
Resistance Level $0.24 $2.23
Average True Range (ATR) 0.03 0.07
MACD 0.01 0.00
Stochastic Oscillator 53.85 57.89

Price Performance

Historical Comparison
NCRA
BMRA

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Share on Social Networks: